{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Methods of determining dose of IL-31 agonist to treat pulmonary inflammation", "item": "https://www.patentleaderboard.com/patent/8029775"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of determining dose of IL-31 agonist to treat pulmonary inflammation

Methods of determining dose of IL-31 agonist to treat pulmonary inflammation

US Patent 8029775 · Granted Oct 4, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use2025
Methods of selecting, based on polymorphisms, an inflammatory bowel disease subj2025
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof2024
Optimized anti-TL1A antibodies2022
Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of2022
Methods of treating prurigo nodularis using anti-IL-31RA antibody compositions2022
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use2022
Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof2022
Methods of diagnosing inflammatory bowel disease through RNASET22021